[1]
2022. Evaluation the serum levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in patients with benign and malignant thyroid tumors. Journal of Pharmaceutical Negative Results. 13, 3 (Sep. 2022), 559–571. DOI:https://doi.org/10.47750/pnr.2022.13.03.085.